ArticleInternational ophthalmology2025
Evaluation of corneal and anterior segment alterations following short-term use of topical latanoprostene bunod.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate the short-term effects of topical latanoprostene bunod on corneal and anterior segment parameters in patients with primary open-angle glaucoma (POAG).
methodsA prospective, cross-sectional study was conducted on 30 eyes of 30 patients with POAG. All participants received topical latanoprostene bunod monotherapy. Corneal and anterior segment parameters, including keratometry, corneal thickness, endothelial cell characteristics, and corneal densitometry, were measured before and approximately after one month of treatment using the Pentacam HR and non-contact specular microscopy. Statistical analysis was performed to compare pre- and post-treatment measurements.
resultsNo significant changes were observed in corneal keratometry, endothelial cell density, hexagonality, or anterior chamber parameters including anterior chamber angle, depth, and volume following treatment (p > 0.05 for all). Although reductions in central corneal thickness and thinnest corneal thickness were noted, these changes were not statistically significant (p > 0.05 for both). A significant decrease in densitometric parameters was observed in most corneal zones after treatment, including anterior, central, posterior, and total thickness measurements (p < 0.05 for all). In contrast, no significant change was found in the peripheral 10-12 mm zones (p > 0.05 for all).
conclusionShort-term use of latanoprostene bunod reduced corneal densitometry values, suggesting improved corneal transparency without significantly affecting corneal thickness, endothelial cell characteristics, or anterior segment parameters. Further long-term studies with larger sample sizes are needed to evaluate its prolonged effects on corneal health.
Indexed as
Identifiers
40540210What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.